Relmada Therapeutics, Inc. (RLMD)

NASDAQ: RLMD · IEX Real-Time Price · USD

2.94

-0.21 (-6.67%)

At close: Sep 28, 2023, 4:00 PM

2.75

-0.19 (-6.46%)

Pre-market: Sep 29, 2023, 7:09 AM EDT

Balance Sheet (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	5.4	44.44	2.5	36.28	2.24	1.71	8.5	22.47
Short-Term Investments	142.93	167.47	114.6	80.16	0	0	0	0
Cash & Cash Equivalents	148.32	211.91	117.09	116.44	2.24	1.71	8.5	22.47
Cash Growth	-30.01%	80.98%	0.56%	5100.82%	30.89%	-79.88%	-62.17%	-
Receivables	0.51	0.09	0.17	0.24	0.35	0.63	0.23	0
Other Current Assets	4.04	11.3	0.82	0.26	0.15	0.13	0.57	1.5
Total Current Assets	152.87	223.3	118.07	116.94	2.74	2.47	9.3	23.97
Property, Plant & Equipment	0	0	0	0.01	0.01	0	0.53	0.02
Other Long-Term Assets	0.03	0.03	0.11	0.19	0.3	0.36	0.41	0.4
Total Long-Term Assets	0.03	0.03	0.11	0.2	0.31	0.36	0.95	0.42
Total Assets	152.91	223.33	118.19	117.14	3.05	2.84	10.24	24.39
Accounts Payable	5.26	11.19	8.35	0.52	0.77	0.53	1.26	0.84
Current Debt	0	0	0	0.11	0.29	0.28	0.27	0.26
Other Current Liabilities	7.21	3.87	4.26	0.82	4.85	0.57	1.53	14.48
Total Current Liabilities	12.47	15.06	12.6	1.46	5.9	1.38	3.06	15.58
Long-Term Debt	0	0	0	0	2.66	0	0	0
Other Long-Term Liabilities	0	0	0	0	0	0	0.14	0
Total Long-Term Liabilities	0	0	0	0	2.66	0	0.14	0
Total Liabilities	12.47	15.06	12.6	1.46	8.56	1.38	3.2	15.58
Total Debt	0	0	0	0.11	2.94	0.28	0.27	0.26
Debt Growth	-	-	-	-96.25%	963.23%	1.10%	3.76%	-
Common Stock	602.55	513.33	284.9	235.54	88.83	86.84	86.14	84.93
Retained Earnings	-462.11	-305.07	-179.32	-119.86	-94.34	-85.38	-79.1	-76.12
Shareholders' Equity	140.44	208.26	105.58	115.68	-5.51	1.46	7.04	8.81
Net Cash / Debt	148.32	211.91	117.09	116.33	-0.7	1.43	8.23	22.21
Net Cash / Debt Growth	-30.01%	80.98%	0.65%	-	-	-82.57%	-62.95%	-
Net Cash Per Share	5.01	12.07	7.51	12.59	-0.22	0.48	2.84	8.94
Working Capital	140.4	208.24	105.47	115.48	-3.17	1.1	6.24	8.39
Book Value Per Share	4.74	11.87	6.77	12.52	-1.76	0.48	2.43	3.54

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).